Laser Approved for Treatment of PCV, CSR<br />
<br />
CLERMONT-FERRAND, France – Quantel Medical today announced CE Mark approval for its Vitra™ PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). Quantel, the sole manufacturer of this laser technology, plans to begin commercializing the laser platform immediately in countries requiring CE registration. <br />
<br />
PCV, a disease of the ...This story is related to the following:Optics and PhotonicsSearch for suppliers of: Lasers |